Q-omics provides the consensus-scored LNCOC1 profile across patient tissues and cancer cell-line models. LNCOC1 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, LNCOC1 is differentially expressed in 13, with the highest sampling consensus in KIRC. Additionally, LNCOC1 RNA expression shows 15,935 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UVM, and KIRC as cancer lineages where LNCOC1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LNCOC1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LNCOC1 survival associations across molecular data types. LNCOC1 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LNCOC1 RNA expression–survival associations across cancer types. High LNCOC1 expression shows unfavorable associations in UVM, MESO, LUAD, KIRP and UCEC, but favorable associations in STAD. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for LNCOC1 RNA expression.
This table summarizes LNCOC1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LNCOC1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LNCOC1 shows lower tumor expression in THCA and higher tumor expression in KIRC, HNSC, BLCA, LIHC and KIRP. The KIRC box plot shows higher LNCOC1 RNA expression in tumor versus normal tissue (log2 FC = +0.328, t-test p < 0.001).
This table shows molecular features associated with LNCOC1 in patient tissues and cancer cell lines. In patient samples, LNCOC1 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
